Cargando…
A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies
OBJECTIVES: This case study addresses: (i) antibiotic treatment options for Staphylococcus aureus bacteraemia (SAB), for both empirical and targeted therapy; (ii) the current status of and priorities for the antibiotic pipeline to ensure access of effective antibiotics for SAB; and (iii) strategies...
Autores principales: | Monnier, Annelie A, Tacconelli, Evelina, Årdal, Christine, Cavaleri, Marco, Gyssens, Inge C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210125/ https://www.ncbi.nlm.nih.gov/pubmed/34222996 http://dx.doi.org/10.1093/jacamr/dlaa034 |
Ejemplares similares
-
Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance
por: Nickerson, Emma K., et al.
Publicado: (2009) -
Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure
por: Monnier, Annelie A, et al.
Publicado: (2018) -
Duration of antibiotic therapy in bacteraemia
por: Wise, Matt P, et al.
Publicado: (2012) -
Risk stratification biomarkers for Staphylococcus aureus bacteraemia
por: Cao, Yi, et al.
Publicado: (2020) -
Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries
por: Buis, D T P, et al.
Publicado: (2022)